The RDIF talked about the use of the Sputnik V vaccine in Serbia


Vaccination with the Russian coronavirus vaccine Sputnik V in Serbia confirmed the high safety of the drug, the Russian Direct Investment Fund (RDIF) said in a statement. “The RDIF announces official vaccination data in Serbia, which confirm the highest safety indicators of the Russian Sputnik V coronavirus vaccine among all drugs included in the country’s national portfolio,” the fund said. Official safety data for the Sputnik V vaccine show no cases of serious adverse events associated with vaccination. There are also no cases of deaths due to vaccination and cases of cerebral venous thrombosis. “The use of Sputnik V contributed to Serbia’s achievement of leading vaccination rates among European countries. To date, more than a quarter of the population (28%) has been fully vaccinated with various drugs in Serbia – twice as much as the average in Europe (14%), “the fund noted.